The European Society
of Human Genetics

Tuesday, June 15

Tuesday, June 15, 2010

Full affiliations are available in the ESHG Programme Planner

08.45 - 10.15

Concurrent Symposia S13 - S15

S13. Beyond the BRCA Genes

S13.1 Can breast cancer mortality be reduced with genetic testing?
Per Hall, Stockholm, Sweden

S13.2 Common genetic variants and cancer risks for BRCA1 and BRCA2 mutation carriers
Antonis Antoniou, Cambridge, United Kingdom

S13.3 Is breast cancer prognosis inherited?
Heli Nevanlinna, Helsinki, Finland


S14. Next Generation Sequencing

S14.1 The 1000 Genomes project
Richard Durbin, Cambridge, United Kingdom

S14.2 International Cancer Genome Consortium
Tom Hudson, Toronto, Canada

S14.3 Next Generation Human Genetics 
Debbie Nickerson, Seattle, WA, United States


S15. Molecular Processes in Neurodegenerative Diseases

S15.1 Using Simple Cells to Model Complex Diseases
Susan L.. Lindquist, Cambridge, MA, United States

S15.2 C. elegans models for neurodegenerative diseases
Ellen Nollen, Groningen, The Netherlands

S15.3 The prion-like aspect of Alzheimer's disease
Mathias Jucker, Tuebingen, Germany

Educational Session ES8. Cystic Fibrosis and Immotile Cilia

ES8.1 Cystic Fibrosis
Batsheva Kerem, Jerusalem, Israel

ES8.2 Immotile cilia
Heymut Omran, Freiburg, Germany

10.15 - 10.45

Coffee Break, Free Poster Viewing, Exhibition


10.45 - 12.15

Concurrent Sessions C12 - C16

C12. Mental retardation
C13. Cytogenetics
C14. Mutation mechanism
C15. Beyond GWAS
C16. Growth and vascular disorders

See Session Details

12.15 - 13.15Lunch, Exhibition, Poster Removal


13.15 - 14.00

Plenary Session PL4

PL4.1 Mendel Lecture
Mary-Claire King, Seattle, WA, United States



14.00 - 15.30

Plenary Session PL5
Journal Awards
Young Investigator & Poster Awards
PL5.1 ESHG Award Lecture

Full affiliations are available in the ESHG Programme Planner

To top